regulatoryaffairs.pharmaceutical-business-review.comRegulation Archives - Pharmaceutical Business review

Pharmaceutical Business review Pharmaceutical Business review is using cookies Continue Learn More Close ☰ Search × HomeAdd Company Advertise with us Contact us Events Suplpiers News Clinical Trials Drug Discovery Packaging & Supply Chain Production & Sales Regulation Advertise With Us Advertise on our extensive network of industry websites and newsletters. Get the PBR newsletter Sign up to our free email to get all the latest PBR news. Home Drug Discovery Drug Discovery Research & Development Pre-clinical Studies Research & Development MorphoSys agrees to acquire Constellation Pharmaceuticals for $1.7bn Drug Discovery Research & Development CBDepot Research & Development Clinical Trials Clinical Trials Patient Enrollment Human Trials Patient Enrollment AM-Pharma enrols first patients in Covid-19 phase III trial Clinical Trials Patient Enrollment FSD Pharma doses first patient in phase 2 Covid-19 trial of FSD201 Clinical Trials Patient Enrollment Regulation Regulation Drug Filing Approvals Rejections Marketing Authorisation Patents Lawsuits Drug Filing Takeda submits New Drug Application for lanadelumab in Japan Drug Filing Approvals Haematology Ocugen signs agreement with Bharat Biotech to distribute Covid-19 vaccine in the US Regulation Drug Filing Production & Sales Production & Sales Production & Sales Manufacturing Launches Recalls Marketing & Sales Manufacturing SciNeuro and Eli Lilly sign exclusive license agreement for alpha-synuclein in Greater China Manufacturing Marketing & Sales Neurology Biogen and Bio-Thera Solutions announce commercialisation and license agreement for BAT1806 Manufacturing Osteoarthritis Packaging & Supply Chain Packaging & Supply Chain Packaging Cold Chain Distribution Storage Packaging Gerresheimer Packaging PCI Pharma announces bottling line expansion at Rockford site Packaging & Supply Chain Packaging Suppliers Suppliers A-Z Suppliers Products & Services Videos White Papers No data found EventsRegister Log In Regulation 31 May 2021 Regulation Approvals Pfizer-BioNTech Covid-19 vaccine gets EU authorisation for adolescents By PBR Staff Writer Comirnaty is claimed to be the first Covid-19 vaccine to be authorised in the EU for use in adolescents. 24 May 2021 Approvals Japan authorises AstraZeneca and Moderna’s Covid-19 vaccines By PBR Staff Writer The Ministry of Health, Labour and Welfare (MHLW) of Japan has granted emergency use authorization for Covid-19 vaccines developed by AstraZeneca and Moderna. 11 May 2021 Infectious Disease Regulation Approvals US FDA approves emergency use of Pfizer-BioNTech Covid-19 vaccine in adolescents By PBR Staff Writer The US Food and Drug Administration (FDA) has expanded the emergency use authorisation (EUA) for Pfizer and BioNTech’s Covid-19 vaccine to include adolescents aged 12 to 15 years. 07 May 2021 Regulation Approvals Russia approves single dose Covid-19 vaccine Sputnik Light By PBR Staff Writer The Russian Direct Investment Fund (RDIF) has announced that a single dose Covid-19 vaccine called Sputnik Light, obtained authorisation for use in the country. 05 May 2021 Regulation Approvals ViiV begins rolling submission for cabotegravir to prevent HIV in US By PBR Staff Writer ViiV Healthcare has initiated a rolling submission of a new drug application (NDA) to the US Food and Drug Administration (FDA) for long-acting cabotegravir to prevent human immunodeficiency virus (HIV). 03 May 2021 Regulation Approvals WHO grants emergency use listing for Moderna’s Covid-19 vaccine By PBR Staff Writer World Health Organization (WHO) has granted emergency use listing (EUL) for Moderna’s Covid-19 vaccine to prevent the infection in people aged 18 years and above. 28 Apr 2021 Regulation Merck signs voluntary licences with Indian companies on molnupiravir By PBR Staff Writer Merck, called as MSD outside the US and Canada, has signed voluntary licensing agreements with five Indian generic drug makers to expand access to Molnupiravir, an experimental oral antiviral Covid-19 therapy. 27 Apr 2021 Regulation Approvals EMA’s CHMP recommends EU approval for AstraZeneca and Merck’s selumetinib By PBR Staff Writer The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended conditional marketing authorisation for AstraZeneca and Merck’s selumetinib to treat paediatric patients aged three years and older with neurofibromatosis type 1 (NF1), symptomatic and inoperable plexiform neurofibromas (PN). 21 Apr 2021 Immunology Marketing Authorisation Launches Johnson & Johnson to resume Covid-19 vaccine roll-out in Europe after EMA review By PBR Staff Writer Johnson & Johnson (J&J) will resume Covid-19 vaccine roll-out in Europe following the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC), which confirmed the overall benefit-risk profile being positive. 19 Apr 2021 Approvals US clearance granted for AstraZeneca’s proposed acquisition of Alexion By PBR Staff Writer The US Federal trade Commission review has granted clearance for AstraZeneca’s proposed acquisition of Alexion Pharmaceuticals, achieving an important milestone in the completion process.Advertise with us Contact us PRIVACY POLICY TERMS AND CONDITIONS © PBR 2021. Part of Progressive Trade Media Ltd. Lost Password Back ⟶ Login Register Get new password Lost Password? Login Registration is...